RxDoctor Payments Data

Jacob Huffman, DPM

Podiatrist · Casselberry, FLNPI 1104383512

Payments from drug & device makers

What this record shows

The money is spread across several categories — education (44.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Reel Surgical, Inc. at 26.6% of the total. Reporting peaked in 2022 at $4,465 and has fallen 65.3% since, to $1,551 in 2025. Among podiatrist clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,132in general payments, 2019–2025

Across 70 payments — averaging $130.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Reel Surgical, Inc.$2K
  • Arthrex$2K
  • Treace Medical Concepts, Inc.$1K
  • Integra Lifesciences Corporation$692
  • Medical Device Business Services, Inc.$475
  • Southern Edge Orthopaedics, Inc.$428
  • plus $2K from 18 others

What the payments were for

  • Speaking & faculty fees$1852%
  • Travel & lodging$1,49516%
  • Food & beverage$3,42437%
  • Education$4,02844%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,132 in reported general payments places this provider in the 90th percentile of 588 podiatrist providers in Florida.

See all podiatrist providers in Florida

Medicare billing

Part B allowed, 2024
$152,409
Medicare patients
317
Services billed
2,051

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox143$2,883
Ketoconazole81$1,701
Mupirocin20$325
Meloxicam39$257
Gabapentin25$140
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$107
Ondansetron OdtOndansetron17$67

Paid to pharmacies, not to this prescriber.

Other podiatrist in Casselberry

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →